Suzanne B. Merrill, MD

Articles by Suzanne B. Merrill, MD

Suzanne B. Merrill

Dr Merrill on Selecting Patients for BCG Plus Durvalumab in High-Risk NMIBC

BySuzanne B. Merrill, MD

November 6th 2026

Suzanne B. Merrill, MD, discusses patient selection and toxicity considerations for BCG plus durvalumab in BCG-naive, high-risk NMIBC.

Latest Updated Articles

Trending on OncLive

FDA Approves Amivantamab and Hyaluronidase for Metastatic HNSCC

BCG Optimization Becomes a Priority as Durvalumab Gains a Role in High-Risk NMIBC

Dr Skoulidis on Divarasib vs Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC

LITESPARK-012, XmAb819, and PE-PE Data Headline Key Kidney Cancer Findings From ESMO 2026

Zanidatamab, CLDN18.2-Directed ADCs, Ivonescimab, and KRAS Inhibitor Data Headline Key GI Cancer Findings From ESMO 2026